Keyword: castration-resistant prostate cancer treatment

News

Bayer Confirms €42.80 per Share Bid for Algeta

30.12.2013 - Germany's Bayer finally confirmed its plans to acquire Norwegian pharmaceutical company Algeta shortly before Christmas. The German chemicals and pharmaceuticals group said Algeta...